|
|
The Expression
and Role of Ubiquilin1 in the Embryonic Development of Xenopus Laevis Aysenur Akoglu, Hicksville Senior HS, Hicksville; Gerald H. Thomsen and Arif Kirmizitas, Department of Biochemistry and Cell Biology and Institute for Cell and Developmental Biology, Stony Brook University | |||
Bone
morphogenetic proteins (BMPs) play important roles in the course of biological
processes such as cell growth, and differentiation. In embryonic development in
Xenopus laevis, BMPs are involved in mesoderm induction during blastula stages,
and mesodermal patterning and neural induction during gastrulation. The dorsal-ventral
patterning of the embryo is regulated by the level of BMP signaling. There are
three inputs regulating the intensity of BMP signal; the level of BMP ligand,
which is highest at ventral region, the level of BMP antagonists, which are secreted
from the organizer, and down-regulation of Smads within the cell by ubiquitination.
Smurf1 is a SMAD ubiquitin ligase that targets the BMP pathway, altering embryonic
development in Xenopus. Recent studies have proven Smurf1 to interact with receptor-regulated
SMADs of BMP pathway resulting in their ubiquitination. Ubiquitinated Smad proteins
are then directed for proteolysis. A yeast two-hybrid screen that was performed,
prior to this experiment, which showed the interaction of Smurf1 with the SMAD
signaling pathway also yielded another protein; Ubiquilin1. Ubiquilin1 has two
ubiquitin-related domains, UBA and UBL. Although there are conflicting reports
in the literature, ubiquilin-1 most probably functions as an adaptor between tagged
proteins and proteosome machinery. We hypothesized that Ubiquilin1 might be involved
in the ubiquitination and proteolysis of Smad1 either by helping Smurf1 to send
Smad proteins into proteosome or it may be involved in a novel mechanism designed
to protect Smad proteins from Smurf-1 regulated ubiquitination by blocking Smurf-1
binding via masking the binding interface. This study was designed in order to
determine which role Ubiquilin1 would take in the embryonic development of Xenopus
laevis. Two distinct tests were carried out to obtain conclusions from separate
perspectives. The expression of Ubiquilin1 was tested by in situ hybridization,
while the impact of this gene was tested by RNA injection. For in situ hybridization,
after an in vitro fertilization, albino and pigmented embryos were collected at
different stages of development. These embryos were fixed in MEMFA fixative and
stored at -20°C in 100% ethanol. After setting the synthesis reaction for
the Sense and Anti-Sense probes, embryos were prepared for in situ hybridization.
They were rehydrated for staining by decreasing the concentration of ethanol.
A Proteinase K treatment and triethanolamine washes followed the procedure. Probes
were hybridized overnight. Dig-labeled probes were detected with alkaline phosphotase-conjugated
anti-digoxygenin antibody. The color reaction was carried out with BM Purple (Roche)
containing levamisole. In situ hybridization has not yet yielded sufficient staining
results; however, tests are still being carried out. On the other hand, the RNA
injections, which were made both on the dorsal and ventral sides in varying concentrations,
have not adequately satisfied the experiment's anticipation yet. Meanwhile, these
injections are being varied, improved and repeated. Again, there are two pathways,
towards which the study can shed light. If findings show that Ubiquilin1 promotes
dorsal development such as head, neural tissue, and mesoderm, it would be concluded
that it plays the same role as Smurf1 in ubiquitination of Smad1. However, if
results produce less neural development and loss of head structures, Ubiquilin1
would then be associated to blocking ubiquitination of Smad1 by Smurf1. This study
was supported by the Simons Foundation. | ||||
Back to Home page